Standout Papers

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Can... 2018 2026 2020 2023 335
  1. Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer (2018)
    Matti Annala, Gillian Vandekerkhove et al. Cancer Discovery

Immediate Impact

3 by Nobel laureates 6 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
2023 Standout
2 intermediate papers

Works of Conrad D. Oja being referenced

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
2019
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
2018 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Conrad D. Oja 670 379 276 328 20 939
Mari Nakazawa 824 425 261 327 23 993
Konstantina Grosios 151 188 404 581 17 1.1k
Wendy Onstenk 390 447 441 254 25 792
A. Delacruz 425 102 341 315 29 880
Andrea Zivi 630 275 181 339 44 926
Fraser Symmans 315 287 591 594 21 1.1k
Sarah B. Noonberg 482 111 200 352 24 913
Ion Cotarla 323 173 534 367 19 1.0k
Susan E. Alters 177 228 168 430 30 1.0k
Anna Fioravanti 190 132 398 325 38 888

All Works

Loading papers...

Rankless by CCL
2026